linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Transwarranty Finance Ltd.
 
Source DateBoard Meeting DateDetails
06 Nov 202513 Nov 2025 Quarterly Results
15 Sep 202518 Sep 2025 Inter alia, to consider and approve Issuance of Unlisted Non-Convertible Debentures by way of private placement.
25 Jul 202531 Jul 2025 Quarterly Results & A.G.M.
25 Jun 202530 Jun 2025 Inter alia, to consider and approve the Issuance of Unlisted Non-Convertible Debentures by way of private placement.
28 Apr 202502 May 2025 Audited Results
28 Jan 202504 Feb 2025 Quarterly Results
11 Nov 202414 Nov 2024 Quarterly Results
16 Sep 202419 Sep 2024 Inter alia, to consider and approve:- To authorise Issue of Unlisted, Unrated, Privately Placed Non- Convertible Debentures (NCD)
06 Aug 202409 Aug 2024 Quarterly Results
25 Jun 202427 Jun 2024 Inter alia, to consider and approve the Raising of funds by issue of Secured and/ or unsecured redeemable non-convertible debentures including subordinated debt on private placement basis.
08 May 202413 May 2024 Preferential Issue of shares
25 Apr 202402 May 2024 Preferential Issue of shares & Employees Stock Option Plan & Audited Results
18 Mar 202421 Mar 2024 IInter alia, to consider and approve Raising of Funds by way of Issue of Secured and/ or unsecured redeemable non-convertible debentures including subordinated debt on private placement basis
06 Feb 202414 Feb 2024 Quarterly Results
02 Nov 202308 Nov 2023 Quarterly Results
19 Jul 202325 Jul 2023 Quarterly Results
19 Jun 202322 Jun 2023 Inter alia, Board Meeting to be held at a Shorter Notice on Thursday, June 22, 2023, to consider and approve the raising of funds by issue of Unsecured Redeemable Non-Convertible Debentures (?NCDs?) on private placement basis of NCDs Type B (Investment of Rs. 1 crore or more per investor) upto Rs. 5 crores.
02 May 202309 May 2023 Audited Results
08 Feb 202314 Feb 2023 Quarterly Results
24 Jan 202330 Jan 2023 Inter-alia, to consider and approve the following: 1. To make 1st & final call of Rs. 7/- per partly paid-up equity shares, on outstanding 2,44,60,568 partly paid-up shares of face value of Rs. 10/- each issued by the Company on rights basis and to decide the Record date and Call payment period for the said call. 2. To approve increasing the limits NCDs from Rs.5 crores to Rs. 20 crores and raising of funds by issue of secured and/or unsecured redeemable non-convertible debentures (NCDs) including subordinated debt on private placement basis of NCDs Type A (Investment of less than Rs. 1 crore per investor) under 23rd Tranche/Series W/2022-23. 3. Raising of funds by issue of unsecured redeemable non-convertible debentures (NCDs) on private placement basis of NCDs Type B (Investment of Rs. 1 crore or more per investor). upto Rs. 10 crores
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.